dactinomycin has been researched along with alprostadil in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Fukui, H; Kikuchi, E; Kitano, H; Matsumoto, M; Morimura, M; Nakano, H; Okamoto, Y; Tsujii, T | 1 |
| Abdel-Malek, ZA; Amornsiripanitch, N; Nordlund, JJ; Swope, VB | 1 |
| Lin, JX; Vilcek, J; Zhang, Y | 1 |
| Hakeda, Y; Hiramatsu, M; Ikeda, E; Kumegawa, M; Kurihara, N; Nakatani, Y; Tsunoi, M | 1 |
| Forray, C; Richelson, E | 1 |
| Higashida, H; Kato, K; Sano, M | 1 |
| Lamberts, SW; Oosterom, R; Verleun, T; Zuiderwijk, J | 1 |
| Endo, N; Harada, S; Nagy, JA; Rodan, GA; Rodan, SB; Sullivan, KA; Thomas, KA | 1 |
| An, S; Goetzl, EJ; Zeng, L | 1 |
| Fang, GD; Guerrant, RL; Marcinkiewicz, M; Sarosiek, J; Thielman, NM | 1 |
14 other study(ies) available for dactinomycin and alprostadil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
D-galactosamine-induced cell damage enhances specific binding of prostaglandin E1 to rat hepatocytes.
Topics: Alprostadil; Animals; Binding Sites; Binding, Competitive; Carbon Tetrachloride; Cells, Cultured; Cycloheximide; Dactinomycin; Galactosamine; Glucagon; Kinetics; Linoleic Acid; Linoleic Acids; Liver; Male; Norepinephrine; Palmitic Acid; Palmitic Acids; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Prostaglandin E | 1992 |
In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Bucladesine; Cell Division; Cycloheximide; Dactinomycin; Dinoprostone; In Vitro Techniques; Melanins; Melanoma; Monophenol Monooxygenase; Prostaglandin D2; Prostaglandins; Prostaglandins A; Prostaglandins D; Prostaglandins E | 1987 |
Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Alprostadil; Bucladesine; Cholera Toxin; Cyclic AMP; Dactinomycin; Enzyme Activation; Fibroblasts; Humans; Interleukin-6; Interleukins; Protein Kinase C; Tetradecanoylphorbol Acetate | 1988 |
Inductive effects of prostaglandins on alkaline phosphatase in osteoblastic cells, clone MC3T3-E1.
Topics: 1-Methyl-3-isobutylxanthine; Alkaline Phosphatase; Alprostadil; Animals; Bone and Bones; Cell Line; Clone Cells; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Enzyme Induction; Mice; Osteoblasts; Prostaglandins; Prostaglandins E; Prostaglandins F | 1985 |
Glucocorticoids potentiate the prostaglandin E1-mediated cyclic AMP formation by a cultured murine neuroblastoma clone.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Alprostadil; Animals; Cell Line; Corticosterone; Cyclic AMP; Cycloheximide; Dactinomycin; Dexamethasone; Drug Synergism; Glucocorticoids; Indomethacin; Kinetics; Mice; Neuroblastoma; Prostaglandins E | 1985 |
Forskolin induction of S-100 protein in glioma and hybrid cells.
Topics: Adenylyl Cyclases; Alprostadil; Animals; Cell Line; Colforsin; Cycloheximide; Dactinomycin; Diterpenes; Glioma; Hybrid Cells; Isoproterenol; Kinetics; Mice; Neuroblastoma; Prostaglandins E; Rats; S100 Proteins; Theophylline | 1985 |
Growth hormone secretion by cultured rat anterior pituitary cells. Effects of culture conditions and dexamethasone.
Topics: Alprostadil; Animals; Cells, Cultured; Culture Media; Dactinomycin; Dexamethasone; Dopamine; Female; Growth Hormone; Kinetics; Pituitary Gland, Anterior; Prolactin; Prostaglandins E; Rats; Rats, Inbred Strains; Somatostatin; Theophylline | 1983 |
Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.
Topics: Alprostadil; Animals; Base Sequence; Cells, Cultured; Cyclic AMP; Cycloheximide; Dactinomycin; Dexamethasone; Dinoprostone; Endothelial Growth Factors; Female; Lymphokines; Molecular Sequence Data; Osteoblasts; Pregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tibia; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1994 |
Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
Topics: Adenine; Alprostadil; Blotting, Northern; Bucladesine; Calcium; Cell Line; Colforsin; Collagenases; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leukemia, T-Cell; Matrix Metalloproteinase 9; Misoprostol; Prostaglandins E, Synthetic; Receptors, Prostaglandin E; RNA, Messenger; T-Lymphocytes; Thapsigargin; Transcription, Genetic; Tumor Cells, Cultured | 1996 |
Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
Topics: Alprostadil; Animals; Bucladesine; Cell Size; CHO Cells; Cholera Toxin; Cricetinae; Cyclic AMP; Cycloheximide; Dactinomycin; Dinoprostone; Diterpenes; Ginkgolides; Humans; Lactones; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Synthesis Inhibitors; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles | 1997 |